Aurora Cannabis Inc. (TSX:ACB)
Market Cap | 325.60M |
Revenue (ttm) | 343.29M |
Net Income (ttm) | 2.27M |
Shares Out | 56.23M |
EPS (ttm) | 0.04 |
PE Ratio | 19.31 |
Forward PE | 36.19 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 442,599 |
Average Volume | 616,421 |
Open | 5.90 |
Previous Close | 5.79 |
Day's Range | 5.61 - 5.90 |
52-Week Range | 4.95 - 9.90 |
Beta | 3.32 |
RSI | 35.99 |
Earnings Date | Jun 20, 2025 |
About Aurora Cannabis
Aurora Cannabis Inc., together with its subsidiaries, engages in production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; sale of medical and consumer use cannabis products; and the propagation of vegetables and floral plants. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Ped... [Read more]
Financial Performance
Financial StatementsNews

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors are adv...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors are a...

Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program
Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program NASDAQ | TSX: ACB EDMONTON, AB , June 26, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDA...

Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products
Proprietary Genetics to be the Highest Potency Medical Cannabis Products Available on the Market NASDAQ | TSX: ACB EDMONTON, AB , June 24, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ...
Aurora Cannabis Falls On Weak 2026 Outlook Despite Record Q4 Revenues

3 Cannabis Stocks For Investors To Secure For Future Gains
The current state of the cannabis sector has people feeling a type of way. To be more descriptive, those who are invested in marijuana stocks are feeling the backlash of the market. For some time, the...

Aurora Cannabis Advises of Second False Article from Investing.com
NASDAQ | TSX: ACB EDMONTON, AB , June 19, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has bec...
Aurora Cannabis denies news of Medleaf Therapeutics acquisition

Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics
NASDAQ | TSX: ACB EDMONTON, AB , June 18, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has bec...

EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story
Shares of Aurora Cannabis Inc (NASDAQ: ACB) fell roughly 20% on Wednesday following the company's fiscal Q4 and full-year 2025 earnings report , even after reporting record-high medical cannabis reve...
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade)
Aurora Cannabis CEO touts ‘pristine’ balance sheet, but shares tumble
The head of Aurora Cannabis says he’s pleased with the state of the company’s balance sheet and its performance in the most recent quarter despite a sharp selloff of its shares on Wednesday.
Aurora Cannabis reduces Q4 net loss
Miguel Martin, chief executive officer of Aurora Cannabis, joins BNN Bloomberg to discuss the company's Q4 earnings.
Aurora Cannabis Inc. (ACB) Q4 2025 Earnings Call Transcript

Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market
Canada-based medical marijuana company Aurora Cannabis Inc.’s (NASDAQ: ACB) stock is trading lower after it released its fourth quarter 2025 earnings . Aurora Cannabis reported a quarterly loss of 24 ...

Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market
Canada-based medical marijuana company Aurora Cannabis Inc.'s ACB stock is trading lower after it released its fourth quarter 2025 earnings.

Aurora Cannabis Shares Fall on Polish Setback, Higher Costs in 4Q
Aurora Cannabis slid Wednesday morning after the company said regulatory headwinds in Poland hit prescription volumes and higher logistics costs pressured margins in the fiscal fourth quarter.
:max_bytes(150000):strip_icc():format(jpeg)/Aurora_Coast_Grow_Room-7f97f9caa8e24c93ad58e9bc4fa65985.jpg)
Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline
Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its international markets, which include the U.S.

Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining more than 50 points on Wednesday. Shares of Aurora Cannabis Inc . (NASDAQ: ACB) fell 20.1% to $4.70 in pre-market trading fol...

Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining more than 50 points on Wednesday.
Aurora Cannabis drops despite Q4 beat amid concerns over international growth

Aurora Cannabis 4Q Loss Narrows as Medical Cannabis Drives Revenue Beat
Aurora Cannabis's loss narrowed in its fiscal fourth quarter thanks to strong growth in its medical-cannabis business.
Aurora Cannabis reports Q4 results

Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter
NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue 1 of $244.4 million, representing 39% YoY growth Delivers Record Adjusted EBITDA 1 of $49.7 million, representing 261% YoY...